Clinigen Acquires SSI Strategy

Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.